$10.23
-0.54-5.06%
Last update: Nov 4, 3:38 PM
Pelthos Therapeutics Inc
PTHSAMEX
The average analyst price target for Pelthos Therapeutics is $52.83, 416.2% above the current price. Of 6 analysts, 6 rate it Buy. Targets range from $40 to $64. The latest change came on Oct 12, 2026, when Lake Street lowered its price target on Pelthos Therapeutics from $50 to $40 and kept a Buy rating.
Price Target Range — 6 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months
